Literature DB >> 21374063

A role of the aryl hydrocarbon receptor in attenuation of colitis.

Keisuke Furumatsu1, Shin Nishiumi, Yuki Kawano, Makoto Ooi, Tomoo Yoshie, Yuuki Shiomi, Hiromu Kutsumi, Hitoshi Ashida, Yoshiaki Fujii-Kuriyama, Takeshi Azuma, Masaru Yoshida.   

Abstract

BACKGROUND AND AIMS: The aryl hydrocarbon receptor (AhR), which is a member of the basic helix-loop-helix/Per-Arnt-Sim homology superfamily, plays an important role in multiple biological functions, and AhR knockout (AhR KO) animals suffer from a variety of organ disorders including a decline in the efficacy of their immune system. In addition, AhR activation is known to aid the maintenance of homeostasis in vivo. In this study, we investigated whether AhR is functionally associated with intestinal immunity. METHODS AND
RESULTS: In in vivo experiments, it was found that dextran sodium sulfate (DSS)-evoked colitis was more severe in AhR KO mice than in C57BL/6J wild type mice. It was also revealed that the administration of DSS increased the expression levels of AhR and CYP1A1 mRNA in the colon epithelium. In addition, oral administration of β-naphthoflavone (βNF), a non-toxic agonist of AhR, suppressed the pathogenesis of DSS-induced colitis. βNF also attenuated DSS-induced colitis. In cell culture experiments, downregulation of AhR in human colon carcinoma SW480 cells enhanced the inflammatory responses evoked by lipopolysaccharide (LPS), and furthermore, AhR activation attenuated LPS-induced inflammatory responses, suggesting that AhR expressing intestinal epithelial cells are involved in the prevention of colitis.
CONCLUSIONS: Our findings about the potential role of AhR activators in epithelial immune regulation aid our understanding of mucosal homeostasis and inflammatory bowl disease (IBD) and suggest that AhR activation has therapeutic value for the treatment of IBD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21374063     DOI: 10.1007/s10620-011-1643-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Association of the dioxin receptor with the Mr 90,000 heat shock protein: a structural kinship with the glucocorticoid receptor.

Authors:  M Denis; S Cuthill; A C Wikström; L Poellinger; J A Gustafsson
Journal:  Biochem Biophys Res Commun       Date:  1988-09-15       Impact factor: 3.575

Review 2.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 3.  Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.

Authors:  Noah P Zimmerman; Rebecca A Vongsa; Michael K Wendt; Michael B Dwinell
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

4.  Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells.

Authors:  Barbara Platzer; Susanne Richter; Doris Kneidinger; Darina Waltenberger; Maximilian Woisetschläger; Herbert Strobl
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

5.  Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands.

Authors:  Kaname Kawajiri; Yasuhito Kobayashi; Fumiaki Ohtake; Togo Ikuta; Yoshibumi Matsushima; Junsei Mimura; Sven Pettersson; Richard S Pollenz; Toshiyuki Sakaki; Takatsugu Hirokawa; Tetsu Akiyama; Masafumi Kurosumi; Lorenz Poellinger; Shigeaki Kato; Yoshiaki Fujii-Kuriyama
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

6.  Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock.

Authors:  Hiroki Sekine; Junsei Mimura; Motohiko Oshima; Hiromi Okawa; Jun Kanno; Katsuhide Igarashi; Frank J Gonzalez; Togo Ikuta; Kaname Kawajiri; Yoshiaki Fujii-Kuriyama
Journal:  Mol Cell Biol       Date:  2009-10-12       Impact factor: 4.272

7.  Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice.

Authors:  Tsutomu Shimada; Kiyoshi Inoue; Yoshihiko Suzuki; Takao Kawai; Emiko Azuma; Takae Nakajima; Masaki Shindo; Kosuke Kurose; Atsushi Sugie; Yutaka Yamagishi; Yoshiaki Fujii-Kuriyama; Masafumi Hashimoto
Journal:  Carcinogenesis       Date:  2002-07       Impact factor: 4.944

Review 8.  The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems.

Authors:  Brian J McMillan; Christopher A Bradfield
Journal:  Mol Pharmacol       Date:  2007-05-29       Impact factor: 4.436

9.  Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor.

Authors:  P Fernandez-Salguero; T Pineau; D M Hilbert; T McPhail; S S Lee; S Kimura; D W Nebert; S Rudikoff; J M Ward; F J Gonzalez
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

10.  Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.

Authors:  H C Rath; M Schultz; R Freitag; L A Dieleman; F Li; H J Linde; J Schölmerich; R B Sartor
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

View more
  59 in total

Review 1.  Ah receptor ligands and their impacts on gut resilience: structure-activity effects.

Authors:  Stephen Safe; Arul Jayaraman; Robert S Chapkin
Journal:  Crit Rev Toxicol       Date:  2020-06-29       Impact factor: 5.635

2.  The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse.

Authors:  Carol J Díaz-Díaz; Sean M Ronnekleiv-Kelly; Manabu Nukaya; Peter G Geiger; Silvia Balbo; Romel Dator; Bryant W Megna; Patrick R Carney; Christopher A Bradfield; Gregory D Kennedy
Journal:  Ann Surg       Date:  2016-09       Impact factor: 12.969

3.  Aryl Hydrocarbon Receptor Activity of Tryptophan Metabolites in Young Adult Mouse Colonocytes.

Authors:  Yating Cheng; Un-Ho Jin; Clint D Allred; Arul Jayaraman; Robert S Chapkin; Stephen Safe
Journal:  Drug Metab Dispos       Date:  2015-04-14       Impact factor: 3.922

4.  Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities.

Authors:  Un-Ho Jin; Syng-Ook Lee; Gautham Sridharan; Kyongbum Lee; Laurie A Davidson; Arul Jayaraman; Robert S Chapkin; Robert Alaniz; Stephen Safe
Journal:  Mol Pharmacol       Date:  2014-02-21       Impact factor: 4.436

5.  Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway.

Authors:  Un-Ho Jin; Sang-Bae Kim; Stephen Safe
Journal:  Chem Res Toxicol       Date:  2015-04-09       Impact factor: 3.739

6.  Is chronic AhR activation by rapidly metabolized ligands safe for the treatment of immune-mediated diseases?

Authors:  Allison K Ehrlich; Nancy I Kerkvliet
Journal:  Curr Opin Toxicol       Date:  2017-02-01

7.  Ligand activation of the Ah receptor contributes to gastrointestinal homeostasis.

Authors:  Iain A Murray; Gary H Perdew
Journal:  Curr Opin Toxicol       Date:  2017-01-19

Review 8.  Intestinal inflammation and the diet: Is food friend or foe?

Authors:  Bryant W Megna; Patrick R Carney; Gregory D Kennedy
Journal:  World J Gastrointest Surg       Date:  2016-02-27

9.  Aryl Hydrocarbon Receptor Activation Synergistically Induces Lipopolysaccharide-Mediated Expression of Proinflammatory Chemokine (c-c motif) Ligand 20.

Authors:  Tejas S Lahoti; Jacob A Boyer; Ann Kusnadi; Gulsum E Muku; Iain A Murray; Gary H Perdew
Journal:  Toxicol Sci       Date:  2015-08-10       Impact factor: 4.849

10.  Loss of aryl hydrocarbon receptor potentiates FoxM1 signaling to enhance self-renewal of colonic stem and progenitor cells.

Authors:  Huajun Han; Laurie A Davidson; Yang-Yi Fan; Jennifer S Goldsby; Grace Yoon; Un-Ho Jin; Gus A Wright; Kerstin K Landrock; Bradley R Weeks; Rachel C Wright; Clinton D Allred; Arul Jayaraman; Ivan Ivanov; Jatin Roper; Stephen H Safe; Robert S Chapkin
Journal:  EMBO J       Date:  2020-08-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.